Evidence map›Paper›PMID 40265473›Full record

ArticleInternational journal of surgery (London, England)2025

Clinical performance of a machine learning-based model for detecting lymph node metastasis in papillary thyroid carcinoma: A multicenter study.

Wei Liu, Jiaojiao Zheng, Liang Han, Weifeng Qu, Qiao Wu, Zhou Yuan, Gaolei Jia, Xiaolong Wang, Linxiong Ye, Jiaqi Zhang and 4 more

Abstract readMulticenter Study
In one paragraph

Article in International journal of surgery (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Wei LiuDepartment of General Surgery (Thyroid & Breast), Zhongshan Hospital, Fudan University, Shanghai, China.
Jiaojiao ZhengDepartment of General Surgery (Thyroid & Breast), Zhongshan Hospital, Fudan University, Shanghai, China.
Liang HanDepartment of Head and Neck Surgery, Tumor Hospital Affiliated to Nantong University, Nantong, Jiangsu, China.
Weifeng QuDepartment of General Surgery (Thyroid & Breast), Zhongshan Hospital, Fudan University, Shanghai, China.
Qiao WuDepartment of General Surgery (Thyroid & Breast), Zhongshan Hospital, Fudan University, Shanghai, China.
Zhou YuanDepartment of General Surgery, Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gaolei JiaDepartment of Thyroid surgery, Xuzhou Central Hospital, Xuzhou, China.
Xiaolong WangDepartment of General Surgery, Xuhui Central Hospital, Shanghai, China.
Linxiong YeDepartment of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
Jiaqi ZhangDepartment of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
Shisheng ZhangDepartment of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
Xuanye CaoDepartment of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
Ying LiuDepartment of Engineering Research Center, Southeast University-Affiliated Xuzhou Central Hospital, Jiangsu, China.
Zhilong AiDepartment of General Surgery (Thyroid & Breast), Zhongshan Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Papillary thyroid carcinoma (PTC) is a common endocrine malignancy with a generally favorable prognosis, but lymph node metastasis (LNM) complicates treatment and increases recurrence risk. Current preoperative methods like neck ultrasound often miss LNM, leading to unnecessary surgeries. This study developed a non-invasive, artificial intelligence (AI)-driven predictive model for LNM using gene expression data from 157 PTC patients and validated it with qRT-PCR across 807 participants from multiple centers. The model focused on three key genes - RPS4Y1, PKHD1L1, and CRABP1 - chosen for their predictive strength. A random forest algorithm achieved high accuracy, with an AUROC of 0.992 in training and 0.911-0.953 in external validation. RPS4Y1 emerged as a standout predictor, showing the strongest distinction between metastatic and non-metastatic cases. The study also identified immune-related pathways, such as TGF-β signaling and cancer-associated fibroblast activation, as critical in metastasis. This gene expression-based model offers a non-invasive, cost-effective solution for predicting LNM, providing valuable insights to guide surgical decisions and reduce unnecessary procedures, ultimately improving patient outcomes.

Indexed as

Lymphatic MetastasisMachine LearningThyroid Cancer, PapillaryThyroid NeoplasmsAdultFemaleHumansMaleMiddle Agedmachine learningprecision oncologyPTC metastasis

Identifiers

PMID40265473
PMCPMC12165525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.